平成8年
Rosenberg SA, Kawakami Y, Robbins PF, and Wang R. Identification of the genes encoding cancer antigens: Implications for cancer immunotherapy.Adv. Adv Cancer Res.70:145-177.1996
Kawakami Y, Robbins PF and Rosenberg SA. Human melanoma antigens recognized by T cells and their use for immuno-gene therapy. The Keio J Med.45(2):100-108.1996 Jun
Kawakami Y and Rosenberg SA. T-cell recognition of self antigens as tumor rejection antigens. Immunol Res.15(3):179-190.1996
Restifo NP, Marincola F, Kawakami Y, Taubenberger J, Yannelli JR and Rosenberg SA. The loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J Natl Cancer Inst.88(2):100-108.1996 Jan
Robbins PF, El-Gamil M, Li YF, Kawakami Y, Loftus D, Appella E and Rosenberg SA. A mutated b2-catenin gene encodes a melanoma – specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med.183(3):1185-1192.1996 Mar
Wang RF, Parkhurst MR, Kawakami Y, Robbins PF and Rosenberg SA. Utilization of an alternative open reading frame of a normal gene in generating human cancer antigen. J Exp Med.183(3):1131-1140.1996 Mar
Zhai Y, Yang JC, Kawakami Y, Spiess P, Wadsworth SC, Cardoza LM, Couture LA, Smith AE and Rosenberg SA. Antigen-specific tumor vaccine: Development and characterization of recombinant adenoviruses encoding MART-1 or gp100 for cancer therapy. J Immunol.156(2):700-710.1996 Jan
Marincola FM, Hijazi Y, Fetch P, Salgaller M, Rivoltini L, Cormier J, Simmons TB, Duray PH, Herlyn M, Kawakami Y and Rosenberg SA. Analysis of expression of the melanoma associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in In Situ legions. J Immunother.19(3):192-205.1996 May
Robbins PF and Kawakami Y. Human tumor antigens recognized by T cells, Curr Opin Immun.8(5):628-636.1996 Oct
Parkhurst MR, Salgaller ML, Southwood S, Robbins PF, Sette A, Rosenberg SA and Kawakami Y. Improved induction of melanoma reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201 binding residues. J Immunol.157(6):2539-2548.1996 Sep
Wang RF., E.Appella, Y.Kawakami, X.Kang, and SA.Rosenberg. Identification of TRP2 as a human tumor antigen recognized by cytotoxic T lymphocytes.J Exp Med.184(6):2207-2216.1996 Dec
Kawakami Y, Robbins PF and Rosenberg SA. Identification of human melanoma antigens recognized by T-cells and their use for immuno-gene-therapy. in “New Research in Immunological Diseases” N.Minato, M.Miyasaka, and K.Yamamoto, eds. Academic press, Tokyo:123-131.1996
Kawakami Y, Robbins PF, Wang RF and Rosenberg SA. Identification of tumor regression antigens in melanoma. In “ Important Advances in Oncology.” V. DeVita, S. Hellman, S.A.Rosenberg eds. J.B. Lippincott Co. Philadelphia.3-21.1996
Kawakami Y, Robbins PF, Wang RF and Rosenberg SA. Identification of Melanoma antigens by T lymphocytes and their use in the immunothrapy of cancer. In “Princple and Practice of Oncology. Update”. V. DeVita, S. Hellman, S.A.Rosenberg eds. J.B. Lippincott Co. Philadelphia,.10(12):1-20.1996 Dec